Comparing baseline_with_answers_full_allchunks_v1.json -> baseline_with_answers_full_allchunks_evidselect_v2.json
questions: old=13 new=13 common=13

## Aggregate
| Metric | Old | New | Delta |
|---|---:|---:|---:|
| Avg retrieval latency (s) | 6.98 | 7.41 | +0.42 |
| Avg generation latency (s) | 10.64 | 10.99 | +0.35 |
| Citation warning rows | 0 | 0 | +0.00 |
| Invalid cited-PMID rows | 0 | 0 | +0.00 |
| Manual citation extraction mismatches | 0 | 0 | +0.00 |
| Rows with Evidence basis | 13 | 13 | +0.00 |
| Rows with review flags | 1 | 1 | +0.00 |

## GLP-1 agonists and cardiovascular outcomes
generation: 14.018s -> 12.766s (-1.25s)
answer chars: 2762 -> 2528 (-234.00)
Evidence basis: True -> True
cited PMIDs: 3 -> 3; overlap 1/5 union
added citations: 30223891, 35546664
removed citations: 29445896, 31422062
review flags: none -> ['causal term:causes']
old short answer: GLP-1 receptor agonists are associated with a reduced risk of major adverse cardiovascular events (MACE), cardiovascular mortality, and all-cause mortality in patients with type 2 diabetes, with a moderate to high qualit…
new short answer: GLP-1 receptor agonists are associated with reduced risk of death from cardiovascular causes, fatal or non-fatal stroke, and a composite kidney outcome in patients with type 2 diabetes, but the evidence for cardiovascula…

## SGLT2 inhibitors kidney outcomes
generation: 11.392s -> 14.282s (+2.89s)
answer chars: 2369 -> 2384 (+15.00)
Evidence basis: True -> True
cited PMIDs: 4 -> 4; overlap 2/6 union
added citations: 33789035, 34129237
removed citations: 33663074, 36579248
old short answer: SGLT2 inhibitors are associated with reduced risk of kidney-related outcomes, including acute kidney injury, end-stage kidney disease, and kidney death, in patients with type 2 diabetes mellitus and chronic kidney diseas…
new short answer: SGLT2 inhibitors are associated with reduced risk of kidney outcomes, including end-stage kidney disease, acute kidney injury, and kidney death, in patients with type 2 diabetes.

## aspirin for primary prevention cardiovascular disease
generation: 10.492s -> 11.179s (+0.69s)
answer chars: 2817 -> 3688 (+871.00)
Evidence basis: True -> True
cited PMIDs: 5 -> 3; overlap 3/5 union
removed citations: 20429671, 32924644
old short answer: Low-dose aspirin is associated with a small absolute risk reduction in major cardiovascular disease events and a small absolute increase in major bleeding in primary prevention populations. The evidence suggests that asp…
new short answer: The evidence suggests that low-dose aspirin may be associated with a small absolute risk reduction in major cardiovascular disease events, but the evidence is insufficient to recommend universal use or avoidance for prim…

## beta blockers and mortality in heart failure
generation: 10.302s -> 9.789s (-0.51s)
answer chars: 3001 -> 2942 (-59.00)
Evidence basis: True -> True
cited PMIDs: 2 -> 7; overlap 2/7 union
added citations: 9129883, 10937984, 11024409, 11851582, 36999245
old short answer: Beta-blockers are associated with a reduction in mortality in patients with heart failure, with a consistent 30% reduction in mortality and a 40% reduction in hospitalizations in patients with class II and III heart fail…
new short answer: Beta-blockers are associated with reduced mortality in patients with heart failure, with a consistent 30% reduction in mortality and a 40% reduction in hospitalizations in patients with class II through IV heart failure…

## does aspirin reduce colorectal cancer risk?
generation: 10.267s -> 11.227s (+0.96s)
answer chars: 2333 -> 2618 (+285.00)
Evidence basis: True -> True
cited PMIDs: 2 -> 6; overlap 1/7 union
added citations: 8037405, 9556464, 22036019, 25252097, 33594505
removed citations: 35348611
old short answer: The retrieved evidence suggests an association between aspirin use and reduced risk of colorectal cancer, but the evidence is not uniform and the relationship may be influenced by various factors.
new short answer: The retrieved evidence suggests an association between aspirin use and reduced risk of colorectal cancer, but the evidence is not uniform and some studies show no association.

## does metformin reduce cancer risk?
generation: 9.607s -> 10.427s (+0.82s)
answer chars: 2365 -> 2479 (+114.00)
Evidence basis: True -> True
cited PMIDs: 5 -> 4; overlap 3/6 union
added citations: 32424261
removed citations: 24172091, 25329671
old short answer: The retrieved evidence suggests an association between metformin use and reduced cancer risk.
new short answer: The retrieved evidence suggests an association between metformin use and lower risk of developing lung cancer, but higher risk of high-grade prostate cancer and overall prostate cancer.

## exercise and insulin sensitivity
generation: 10.346s -> 9.245s (-1.10s)
answer chars: 2899 -> 2347 (-552.00)
Evidence basis: True -> True
cited PMIDs: 4 -> 4; overlap 3/5 union
added citations: 24474665
removed citations: 1886478
old short answer: Regular exercise has a significant benefit on insulin sensitivity in adults with type 2 diabetes mellitus and this may persist beyond 72 hours after the last exercise session [27535644].
new short answer: Regular exercise has a significant benefit on insulin sensitivity in adults with type 2 diabetes mellitus and may persist beyond 72 hours after the last exercise session [27535644]. Exercise is a valuable primary care an…

## ketogenic diet epilepsy adults
generation: 7.264s -> 9.345s (+2.08s)
answer chars: 1917 -> 2348 (+431.00)
Evidence basis: True -> True
cited PMIDs: 4 -> 5; overlap 2/7 union
added citations: 18358881, 24380692, 32199222
removed citations: 27149186, 36637840
old short answer: The ketogenic diet is associated with a reduction in seizure frequency in adults with intractable epilepsy, with efficacy rates ranging from 34% to 52% and compliance rates ranging from 38% to 56%.
new short answer: The ketogenic diet is associated with a potential efficacy rate of 42% in adults with intractable epilepsy, with a combined compliance rate of 45%. The diet may be more effective in adults with focal epilepsy.

## mechanism of metformin AMPK activation
generation: 10.748s -> 9.51s (-1.24s)
answer chars: 2147 -> 1815 (-332.00)
Evidence basis: True -> True
cited PMIDs: 7 -> 7; overlap 4/10 union
added citations: 21098866, 31822720, 34555415
removed citations: 20844250, 23066988, 29344225
old short answer: Metformin activates AMP-activated protein kinase (AMPK) through multiple pathways, including mitochondria-derived reactive nitrogen species (RNS), the c-Src/PI3K pathway, and the LKB1/AMPK pathway, with potential involve…
new short answer: Metformin activates AMP-activated protein kinase (AMPK) through multiple mechanisms, including mitochondria-derived reactive nitrogen species (RNS), inositol polyphosphate multikinase (IPMK), and AMPK-independent effects…

## omega-3 supplementation cardiovascular prevention
generation: 11.498s -> 14.483s (+2.99s)
answer chars: 2691 -> 3333 (+642.00)
Evidence basis: True -> True
cited PMIDs: 4 -> 7; overlap 3/8 union
added citations: 19609891, 33092130, 35187035, 36103100
removed citations: 33660821
review flags: ['causal term:causes'] -> none
old short answer: The evidence suggests that omega-3 supplementation may be associated with a reduced risk of cardiovascular events, particularly in high-risk populations, but the evidence is not conclusive and may be influenced by residu…
new short answer: Omega-3 supplementation may reduce the risk of major cardiovascular events, myocardial infarction, and cardiovascular death, but the evidence is not conclusive and may be influenced by the type of omega-3 fatty acid supp…

## p53 mutation and cancer prognosis
generation: 11.812s -> 11.42s (-0.39s)
answer chars: 2604 -> 2639 (+35.00)
Evidence basis: True -> True
cited PMIDs: 4 -> 7; overlap 1/10 union
added citations: 24696834, 27239089, 27885271, 34902987, 35743117, 37373225
removed citations: 23739040, 25051299, 37372326
old short answer: The relationship between p53 mutation and cancer prognosis is complex and influenced by various factors, including the type of mutation, the presence of other genetic alterations, and the specific cancer type.
new short answer: The relationship between TP53 mutations and cancer prognosis is complex and influenced by various factors, including the type of cancer, the presence of other genetic alterations, and the expression of p53 isoforms.

## statins and risk of dementia
generation: 10.473s -> 10.382s (-0.09s)
answer chars: 2319 -> 2418 (+99.00)
Evidence basis: True -> True
cited PMIDs: 3 -> 5; overlap 2/6 union
added citations: 23461525, 30045255, 34871380
removed citations: 32583471
old short answer: The retrieved evidence suggests an association between statin use and a lower risk of dementia, particularly in patients with stroke, atrial fibrillation, and hypercholesterolemia, but the evidence is not sufficient to e…
new short answer: The retrieved evidence suggests an association between statin use and a reduced risk of dementia, with some studies indicating a 10-20% risk decrement.

## vitamin D supplementation and respiratory infections
generation: 10.038s -> 8.805s (-1.23s)
answer chars: 3021 -> 2571 (-450.00)
Evidence basis: True -> True
cited PMIDs: 4 -> 4; overlap 1/7 union
added citations: 23326099, 26310436, 36259029
removed citations: 23220552, 25476069, 33294117
old short answer: Vitamin D supplementation may be associated with a reduced risk of respiratory infections, particularly in individuals with vitamin D deficiency.
new short answer: Vitamin D supplementation may have a moderate effect on reducing non-influenza respiratory viral infections, but the evidence is inconsistent regarding its effect on influenza and other respiratory infections.
